ViroPharma Denied Block On Generic Vancocin Approval
A Washington federal judge on Wednesday ended ViroPharma Inc.'s bid to cancel the U.S. Food and Drug Administration's approval of generic versions of antibiotic Vancocin and extend its exclusive rights to...To view the full article, register now.
Already a subscriber? Click here to view full article